Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent by Merchant, Mark, Ma, Xiaolei, Maun, Henry R, Zheng, Zhong, Peng, Jing, Romero, Mally, Huang, Arthur, Yang, Nai-ying, Nishimura, Merry, Greve, Joan, Santell, Lydia, Zhang, Yu-Wen, Su, Yanli, Kaufman, Dafna W, Billeci, Karen L, Mai, Elaine, Moffat, Barbara, Lim, Amy, Duenas, Eileen T, Phillips, Heidi S, Xiang, Hong, Young, Judy C, Vande Woude, George F, Dennis, Mark S, Reilly, Dorothea E, Schwall, Ralph H, Starovasnik, Melissa A, Lazarus, Robert A, Yansura, Daniel G

Get full text

Allosteric Peptide Activators of Pro-Hepatocyte Growth Factor Stimulate Met Signaling by Landgraf, Kyle E., Santell, Lydia, Billeci, Karen L., Quan, Clifford, Young, Judy C., Maun, Henry R., Kirchhofer, Daniel, Lazarus, Robert A.

Get full text

Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist by Kirchhofer, Daniel, Lipari, Michael T, Santell, Lydia, Billeci, Karen L, Maun, Henry R, Sandoval, Wendy N, Moran, Paul, Ridgway, John, Eigenbrot, Charles, Lazarus, Robert A

Get full text

Structural and Functional Basis of the Serine Protease-like Hepatocyte Growth Factor β-Chain in Met Binding and Signaling by Kirchhofer, Daniel, Yao, Xiaoyi, Peek, Mark, Eigenbrot, Charles, Lipari, Michael T., Billeci, Karen L., Maun, Henry R., Moran, Paul, Santell, Lydia, Wiesmann, Christian, Lazarus, Robert A.

Get full text

Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells by Lee, Chingwei V., Hymowitz, Sarah G., Wallweber, Heidi J., Gordon, Nathaniel C., Billeci, Karen L., Tsai, Siao-Ping, Compaan, Deanne M., Yin, JianPing, Gong, Qian, Kelley, Robert F., DeForge, Laura E., Martin, Flavius, Starovasnik, Melissa A., Fuh, Germaine

Get full text

Effect of IFN-γ on the killing of S. aureus in human whole blood : Assessment of bacterial viability by CFU determination and by a new method using alamarBlue by DeForge, Laura E, Billeci, Karen L, Kramer, Susan M

Get full text

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent by Merchant, Mark, Ma, Xiaolei, Maun, Henry R., Zheng, Zhong, Peng, Jing, Romero, Mally, Huang, Arthur, Yang, Nai-ying, Nishimura, Merry, Greve, Joan, Santell, Lydia, Zhang, Yu-Wen, Su, Yanli, Kaufman, Dafna W., Billeci, Karen L., Mai, Elaine, Moffat, Barbara, Lim, Amy, Duenas, Eileen T., Phillips, Heidi S., Xiang, Hong, Young, Judy C., Woude, George F. Vande, Dennis, Mark S., Reilly, Dorothea E., Schwall, Ralph H., Starovasnik, Melissa A., Lazarus, Robert A., Yansura, Daniel G.

Get full text

Structural and Functional Basis of the Serine Protease-like Hepatocyte Growth Factor β-Chain in Met Binding and Signaling by Daniel Kirchhofer, Xiaoyi Yao, Mark Peek, Charles Eigenbrot, Michael T. Lipari, Karen L. Billeci, Henry R. Maun, Paul Moran, Lydia Santell, Christian Wiesmann, Robert A. Lazarus

Get full text

Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Commentary by RADER, Christoph, BARBAS, Carlos F, QIAN GONG, KELLEY, Robert F, DEFORGE, Laura E, MARTIN, Flavius, STAROVASNIK, Melissa A, FUH, Germaine, LEE, Chingwei V, HYMOWITZ, Sarah G, WALLWEBER, Heidi J, GORDON, Nathaniel C, BILLECI, Karen L, TSAI, Siao-Ping, COMPAAN, Deanne M, JIANPING YIN

Get full text

Effect of IFN-γ on the killing of S. aureus in human whole blood by DeForge, Laura E, Billeci, Karen L, Kramer, Susan M

Get full text